-transparent.png){kind=logo}
The synthesis and anticonvulsant activity of a number of 2-aryl-5-guanidino-1,3,4 thiadiazoles are described. The unsubstituted guanidine 2a was found to possess potent anticonvulsant properties; considerable reduction or loss of activity however was observed with the majority of the substituted guanidines. Incorporation of the guanidine group into an imidazoline ring also resulted in a loss of activity. Secondary pharmacological evaluation confirmed the anticonvulsant properties of 2a but also revealed that the compound exhibited a considerable degree of sedative activity.
Related Publications
C B Chapleo, and
P L Myers, and
A C Smith, and
I F Tulloch, and
S Turner, and
D S Walter
November 1986,
Journal of medicinal chemistry,
C B Chapleo, and
P L Myers, and
A C Smith, and
I F Tulloch, and
S Turner, and
D S Walter
January 2022,
Scientifica,
C B Chapleo, and
P L Myers, and
A C Smith, and
I F Tulloch, and
S Turner, and
D S Walter
March 2009,
European journal of medicinal chemistry,
C B Chapleo, and
P L Myers, and
A C Smith, and
I F Tulloch, and
S Turner, and
D S Walter
June 2002,
Journal of agricultural and food chemistry,
C B Chapleo, and
P L Myers, and
A C Smith, and
I F Tulloch, and
S Turner, and
D S Walter
October 2022,
Molecules (Basel, Switzerland),
C B Chapleo, and
P L Myers, and
A C Smith, and
I F Tulloch, and
S Turner, and
D S Walter
October 2010,
European journal of medicinal chemistry,
C B Chapleo, and
P L Myers, and
A C Smith, and
I F Tulloch, and
S Turner, and
D S Walter
January 1958,
Il Farmaco; edizione scientifica,
C B Chapleo, and
P L Myers, and
A C Smith, and
I F Tulloch, and
S Turner, and
D S Walter
April 2006,
European journal of medicinal chemistry,
C B Chapleo, and
P L Myers, and
A C Smith, and
I F Tulloch, and
S Turner, and
D S Walter
February 2011,
Journal of enzyme inhibition and medicinal chemistry,
C B Chapleo, and
P L Myers, and
A C Smith, and
I F Tulloch, and
S Turner, and
D S Walter
November 1985,
Chemical & pharmaceutical bulletin,
